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Dopaminergic (DA) neuron-like cells obtained through direct reprogramming of primary human fibroblasts offer exciting op-
portunities for treatment of Parkinson’s disease. A significant obstacle is the low efficiency of conversion during the repro-
gramming process. Here, we demonstrate that the suppression of p53 significantly enhances the efficiency of transcription fac-
tor-mediated conversion of human fibroblasts into functional dopaminergic neurons. In particular, blocking p53 activity using 
a dominant-negative p53 (p53-DN) in IMR90 cells increases the conversion efficiency by 5–20 fold. The induced DA neu-
ron-like cells exhibit dopamine neuron-specific gene expression, significant dopamine uptake and production capacities, and 
enables symptomatic relief in a rat Parkinson’s disease model. Taken together, our findings suggest that p53 is a critical barrier 
in direct reprogramming of fibroblast into dopaminergic neurons. 
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Parkinson’s disease (PD) is a chronic and progressive 
movement disorder, which involves the selective loss of 
midbrain dopamine neurons. One of the promising ap-
proaches for PD treatment is cell replacement therapy. 
Generation of dopaminergic (DA) neurons cells has been 
achieved through the use of pluripotent cells, either embry-
onic stem cells or induced pluripotent stem cells (iPSCs) 
[15]. Similar to embryonic stem cells, iPSCs have the abil-
ity to permanently self-renew and also produce multiple cell 
types through directed differentiation. In theory, large-scale 
production of differentiated DA neuron cells from iPS cells 
can be achieved following established protocols [6,7]. Fur-
thermore, because iPSCs can be derived from somatic cells, 
it overcame the many obstacles that embryonic stem cells 
face. However, there remain some challenges in using 
iPSC-derived DA neurons for PD treatment. One obstacle is 
teratoma-formation in vivo [8]. Such risks need to be ad-
dressed before iPS cell-based cell replacement therapy for 
Parkinson’s disease can become a reality.  
As an alternative to iPSC-derived DA cells, directly re-
programed DA cells derived from somatic cells have some 
unique advantages. With the direct reprogramming method, 
the use of cancer inducing factors (e.g., myc), and the in-
termediate steps for inducing and selecting embryoid  
bodies and rosette-neural-precursors are skipped, which 
significantly reduces the risk of teratoma-formation. Direct 
reprogramming of mouse or human fibroblasts into dopa-
minergic neurons has been achieved through ectopic ex- 
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pression of different transcription factors [913]. Vier-
buchen et al. [14] identified a combination of three factors, 
Ascl1, Brn2 and Myt1l, that suffice to directly convert 
mouse embryonic fibroblasts (MEFs) into functional neu-
rons in vitro. The conversion efficiency ranged from 1.8% 
to 7.7% in MEFs. Caiazzo et al. [9] demonstrated a combi-
nation of three factors, Mash1, Nurr1 and Lmx1a, that were 
able to generate functional dopaminergic neurons directly 
from mouse and human fibroblasts. The conversion effi-
ciency was 18%±3% when calculated as the fraction of 
GFP+ cells among mouse embryonic fibroblasts from TH 
(tyrosine hydroxylase)-GFP transgenic mice. In human 
IMR90 fibroblasts, the efficiency of conversion was 
6%±2%. In our own published study [11], we show that a 
combination of five transcriptional factors Mash1, Ngn2, 
Sox2, Nurr1, and Pitx3 could directly reprogram human 
fibroblasts into dopaminergic neuron cells. The overall fre-
quency of fibroblasts to dopaminergic neurons conversion 
was around 1%2% of the gene-transduced IMR90 cells. 
Thus the conversion efficiency of human cells into DA 
neurons is low taking account of different calculation 
methods. There is clearly a need to increase the efficiency 
of direct reprogramming from primary human cells into DA 
cells.  
In our previous study, we observed that during the repro-
gramming process, most human fibroblast (IMR90) cells 
died from detachment and sloughing off, which was the 
main reason leading to low conversion efficiency. In the 
present study, we examined the strategy of boosting direct 
reprogramming efficiency through inhibition of the tumor 
suppressor gene p53. Previously, it has been shown that p53 
and several other tumor genes are significant barriers for the 
induction of iPSC [1519]. We reasoned that it may play a 
similar role in reprogramming human fibroblasts into DA 
neurons. Thus its inhibition may lead to increased efficiency 
of deriving DA neurons through direct reprogramming. 
1  Materials and methods 
1.1  Cell culture and lentiviral vector transduction 
Early passage human fibroblasts IMR90 (from fetal lung) 
were maintained in standard medium (MEM+non-essential 
amino acid+10% bovine serum) and sub-cultured every 35 d 
as necessary. Human induced dopaminergic neuron-like 
cells (HiDA) were generated using an established protocol 
with lentiviral vectors encoding transcription factors [9,11], 
and cultured in the neural induction medium consisting of 
Dulbecco’s modified Eagle’s medium/F12 medium, B27 
supplement (Invitrogen), 25 ng mL1 Sonic Hedgehog (SHH, 
R&D), 25 ng mL1 FGF-8 (R&D), and non-essential amino 
acid (Fisher). The dominant negative form of p53 cDNA 
(p53-DN) was obtained from Addgene and cloned into the 
pLEX lentiviral vector (Open Biosystems, Huntsville, AL, 
USA) and packaged into lentivirus vectors. Lentiviral vec-
tors encoding p53-DN were co- transduced with other re-
programming factors.  
1.2  Immunofluorescence staining 
Immunofluorescence staining on 35-mm glass-bottomed 
dishes was described previously [11]. The primary antibod-
ies were used at dilutions recommended by the manufactur-
ers. The antibodies (anti-human in all cases) used were 
mouse anti-Tuj1 (Covance, 1:800), rabbit anti-TH (Pel- 
Freez, 1:1000), rat anti-DAT (Chemicon, 1:5000), rabbit 
anti-DDC (Chemicon, 1:500), rat anti-Serotonin (Chemicon, 
1:200), goat anti-ChAT (Chemicon, 1:100), mouse anti-HN 
(Millipore, 1:200). The immunostaining was developed with 
appropriate fluorescent-tagged secondary antibodies (Invi-
trogen, Carlsbad, CA, USA). In all cases, cellular nuclei 
were stained with DAPI in VectorShield mounting medium 
(Vector Laboratories, Burlingame, CA, USA). Images were 
collected with a Ziess microscope.  
1.3  Calculation of transduction efficiency 
To calculate the efficiency of neuronal induction, the aver-
age number of neuron-specific marker-positive cells present 
in DAPI-positive cells of 10 randomly selected ×20 visual 
fields was used to determine the fraction of total number of 
neurons present. The total numbers of cells were determined 
using cells cultured in parallel wells or dishes. Statistical 
analyses were performed using one-way ANOVA in SPSS 
10.0. 
1.4  Real-time PCR  
Total RNA was extracted using RNAeasy Mini Kit (Qiagen) 
according to the manufacturer’s instructions. RNA was then 
subjected to complementary DNA synthesis with random 
hexamer primers using Superscript III reverse transcriptase 
(Invitrogen). Quantitative real-time PCR was performed 
using SYBR Green PCR Master Mix (Qiagen). PCR primer 
sequences are available in the previous paper [11]. 
1.5  Quantification of cellular dopamine levels 
Cellular dopamine levels were quantified using HPLC fol-
lowing the previously described method [11,20]. The 
[3H]dopamine uptake assay was also performed by liquid 
scintillation spectrometry using previously published meth-
ods [11,21]. Data were presented as mean±standard error of 
the mean (SEM). 
1.6  Transplantation of cells into a rat model of Par-
kinson’s disease  
We followed a previously established cellular transplant 
protocol [11,22]. Sprague-Dawley rats (Taconic) were le-
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sioned with 6-hydroxydopamine (6-OHDA) following the 
procedure of an established rat Parkinson’s disease model. 
The lesioned rats were transplanted with 3×105 IMR90 cells 
or reprogrammed DA cells into the middle of the striatum 
using stereotactic surgery (coordinates from Bregma 
AP+0.5, ML+2.5, DV−5.0). The animals were evaluated for 
rotational behavior in response to D-amphetamine before 
and after implantation as previously described.  
At the end of experiments, whole brains of the rats were 
fixed and sectioned in the coronal plane on a freezing mi-
crotome at 30 μm thickness and subsequently processed for 
immunofluorescence and immunohistochemistry. The tissue 
sections were stained with antibodies against tyrosine hy-
droxylase and human nuclei protein. 
2  Results 
2.1  Dominant-negative p53 improves the efficiency of 
the conversion process of human induced DA cells 
To investigate the effort of p53 in direct reprogramming  
fibroblasts into dopaminergic neurons, we used a lentivi-
rus-encoded dominant-negative p53 (p53-DN) [23]. Domi-
nant-negative p53 (p53-DN) can suppress p53 function ef-
fectively and was used to boost the efficiency of iPSC in-
duction when Yamanaka factors were used. p53-DN was 
introduced into IMR90 cells together with our 5- transcrip- 
tion factor set (Mash1, Sox2, Ngn2, Nurr1 and Pitx3, 5F) 
following a previously established protocol in our laborato-
ry [11]. We also used a 3-transcription factor (Mash1, Nurr1, 
Lmx1a, 3F) set as a control, which was reported by Caizzo 
et al. [9]. We monitored the number of IMR90 cells after 
they were transfected with 3F, 5F, 5F+p53-DN by use of a 
stably transduced CMV-luc reporter (Figure 1A; Figure 
S1A in Supporting Information). When co-infected with the 
five transcription factors, p53-DN markedly increased the 
number of surviving cells later in the conversion process. 
The survival rate was about 35 fold higher than that of 
non- p53-DN groups (3F, 5F) after 12 d in culture. The sur-
vival rates were similar using either the 3F or 5F protocol 
(Figure 1B). Therefore, expression of the dominant-negative  
 
 
Figure 1  Dominant-negative p53 (p53-DN) increases the survival of 5F transduced IMR90 cells. A, IMR90 cells were initially transduced with a constitu-
tively expressed luciferase gene. They were then infected with lentiviral vectors encoding 3F (Mash1, Nurr1 and Lmx1a), or 5F (Mash1, Sox2, Ngn2, Nurr1 
and Pitx3), or 5F+p53-DN. Cell numbers were subsequently monitored by use of bioluminescence imaging at different times after lentiviral infection. Shown 
are representative images of different cell populations at different time points after infection. DIV, days in vitro. B, Quantitative data of luciferase activities 
in 3F, 5F, and 5F+p53-DN-transduced IMR90 cells. *, 5F vs. 5F+p53-DN, P<0.001. C, Luciferase activities of IMR90Luc cells infected with individual 
lentiviral vectors encoding control (Cont.), Mash1, Sox2, Ngn2, Nurr1, and Pitx3, respectively. The amount of cells was monitored by bioluminescence 
imaging at different times after lentiviral infection. D, Quantitative bioluminescence levels in various lentivirus-transduced IMR90 cells. E, Lack of prolifer-
ation in 5F+p53-DN transduced IMR90 cells. Shown are representative images of BrdU and dopa decarboxylase (DCC) staining at day 4 after sham (top 
panel) or 5F+p53-DN (lower panel) transduction. Scale bar, 200 µm. F, Fraction of cells labeled with BrdU when it was added at different times after 
5F+p53-DN transduction. Error bars indicate standard error of the mean (SEM, n=3). 
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P53 gene can clearly augment the survival rate of the 
IMR90 cells. Figure S1B in Supporting Information shows 
data demonstrating that p53-DN significantly suppressed 
p21 expression, indicating that it was functioning as expected. 
To investigate which transcription factor contributed to 
the cell loss, each of the five transcription factors was indi-
vidually introduced into IMR90 cells with a CMV-Luc re-
porter, and cultured with neuron-specific medium. As 
shown in Figure 1C and D, cell numbers reduced for each of 
the transduced factors, as did for the vector control-   
transduced cells. Cell numbers showed significant decrease 
from day 3 when the cells were cultured with neu-
ron-specific medium without the transcription factors, 
thereby suggesting that exposing the fibroblast cells to neu-
ron-specific medium was the main reason leading to cell 
loss. In addition, compared to IMR90 cells transduced with 
sham vector, Mash1 and Ngn2 are the two transcription 
factors which could incur additional cell loss in the conver-
sion process. Furthermore, Sox2, Nurr1, and Pitx3 attenu-
ated cell loss induced by the neuron-specific medium. 
Because p53 is a tumor suppressor gene and loss of func-
tion of p53 is one of the most common molecular events in 
cancer, p53 inhibition may lead to increased cellular prolif-
eration and higher cancer risk. To investigate this possibility, 
p53-DN was introduced into IMR90 cells together with our 
5-transcription factor set. IMR90 cells were also transduced 
with a sham lentivirus vector as control. The treated IMR90 
cells were cultured with neuron-specific medium containing 
thymidne analog BrdU, a common reagent used for evalu-
ating cell proliferation. Only proliferating cells will be 
marked by BrdU incorporation, which may be detected us-
ing fluorescently-labeled BrdU antibody. BrdU was added 
to the medium at different times after gene transduction. 
Four days after 5F+p53-DN transduction, no cells were la-
beled positive for BrdU, indicating a total lack of cell pro-
liferation 4 d after transduction (Figure 1E and F). Thus it 
appeared that although p53 inhibition improved cellular 
survival during reprogramming, it did not cause cell prolif-
eration.  
To determine the fraction of surviving cells that were 
successfully reprogrammed, the converted cells were 
stained with a neuron-specific marker, Tuj1. Our results 
showed a substantial increase in the number of Tuj1-   
positive cells in the 5F+p53-DN treated IMR90 cells (Fig-
ure 2A and B). The rates of Tuj1-positive on day 20 of 3F, 
5F and 5F+p53-DN treated IMR90 were 9.12%±1.04%, 
34.11%±5.87%, and 35.53%±2.20%, respectively. Thus 
there was about 4-fold increase in the fraction of Tuj1- 
positve cells in 5F or 5F+p53-DN transduced IMR90 com-
pared with that of 3F transduced cells. DAPI staining (Fig-
ure 2A) showed all surviving IMR90 cells on day 20. In 
addition, there was 13.7%±0.5% of initially plated IMR90 
cells that survived in 5F+p53-DN transduced IMR90 cells, 
about 5-fold increase compared with that of 3F 
(1.78%±0.9%) and 5F (2.84%±0.7%) transduced cells. 
Taken into consideration of both Tuj1-positive cells and 
total cell survival, the overall frequency of fibroblast to DA 
neuron conversion was about 20-fold higher in 5F+p53-DN 
transduced IMR90 fibroblasts compared with that in 
3F-transduced cells.  
We also examined the dopaminergic neuron-specific 
molecular markers of the 5F+p53-DN treated IMR90 cells. 
Immunocytochemical analysis showed that 5F+p53-DN 
treated IMR90 cells stained positive for tyrosine hydrox-
ylase (TH), dopamine transporter (DAT), dopamine D2 
receptor (DRD2), and vesicular monoamine transporter 2 
(Vmat2) (Figure 2C and D). Moreover, they stained nega-
tive for serotonin (a marker for serotogenic neurons) and 
ChAT (a marker for cholinergic neurons) (data not shown). 
Quantitative PCR of reverse transcribed mRNAs showed 
that 5F+p53-DN treated IMR90 cells had significantly en-
hanced expression of DA neuron-specific genes, including 
DAT, DDC, DRD2, engrailed 1 (EN1), TH, and Vmat2. 
The expression levels of these genes increased tremendous-
ly (from 200 to 4500-fold) in the reprogrammed cells when 
compared with control fibroblast cells (Figure 3A). Our data 
therefore indicated that the reprogrammed cells (which we 
term as human induced DA cells, or hiDA cell) showed 
characteristics typical of dopaminergic neurons. We also 
examined the expression levels of the endogenous genes for 
the five transcription factors through quantitative PCR 
(Figure 3B). Our results indicated that exogenous expres-
sion of the five transcription factors can activate the expres-
sion of their endogenous counterparts to different extents. 
While the overall gene expression levels are high for these 
genes, activation of their endogenous counterparts are not as 
high, perhaps because the exogenous genes have already 
been expressed at such high levels. 
2.2  Functional characteristics of hiDA 
With evidence that p53 suppression increased the efficiency 
of direct reprogramming from fibroblasts into dopaminergic 
neurons, we next tested the function of the hiDA cells by 
determining the dopamine uptake and production in 
5F+p53-DN converted hiDA cells. Specific DAT-mediated 
dopamine uptake is one of the key characteristic of DA 
neurons. Our results indicated the specific dopamine uptake 
was detected in 5F+p53-DN transduced hiDA cells at day 
24 after transduction (Figure 4A). Dopamine synthesis is 
another key property of dopamine neurons. The secreted 
levels of dopamine in the culturing medium of 5F+p53-DN 
transduced hiDA cells were measured using high-     
performance liquid chromatography. Our results indicated 
that 5F+p53-DN transduced hiDA cells produced a signifi-
cant amount of dopamine, while parental IMR90 fibroblasts 
did not produce any dopamine (Figure 4B). Therefore, our 
results suggested that the directly reprogrammed hiDA cells 
express dopamine-speicfic molecular markers, and show 
characteristic ability to take in and produce dopamine. We  
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Figure 2  Dominant-negative p53 (p53-DN) expression increases reprogramming efficiency of 5F transduced IMR90 cells. A, IMR90 cells were infected 
with lentivirus vector encoding 5F+p53-DN, 5F, and 3F. At 18 d after infection, infected cells were stained with an antibody against Tuj1 (upper panel). 
DAPI staining was used to identify individual cells (middle panel). The lower panel showed the merged pictures. Scale bar, 50 µm. B, Quantification of cells 
that stained positive for Tuj1 and DAPI in 10 randomly selected fields (20×) of observation. Error bars indicate standard error of the mean (SEM, n=5). *, 5F 
vs. 5F+p53-DN, P<0.001. C, Representative images of 5F+p53-DN transduced cells that were stained with various antibodies against general and DA neu-
ron-specific antibodies at 18 days after infection. Scale bar, 200 µm. D, Fraction of cells that stained positive various antibodies in (C). Error bars indicate 
standard error of the mean (SEM, n=5). 
next determined whether reprogrammed hiDA cells could 
establish synaptic connections in culture. We examined the 
expression of a synaptic resident protein, synaptophysin 
(SYP) in 5F+p53-DN treated IMR90 cells. Our results in- 
dicate that hiDA cells strongly express synaptophysin (SYP) 
at the protein level (Figure 4C). When q-RT-PCR was used 
to examine gene expression in the same cells, our results 
show that the mRNA levels for SYP and SYN (α-synuclein), 
another DA-neuron-specific protein, were both increased 
(Figure 4D).  
2.3  Relief of PD symptoms by transplantation of hiDA 
cells into a Parkinsonian rat model  
To investigate whether the reprogrammed dopaminergic 
neurons are functional, we transplanted the reprogrammed 
hiDA cells into 6-hydroxydopamine (6-OHDA)-lesioned 
side of a Parkinsonian rat model (PD). Two days before 
transplantation, cyclosporine (clinical grade, diluted fresh 
daily in saline) was injected intraperitoneally at 10 mg kg1 
per day to prevent immuno-rejection. Sham-treated rats and 
those that received hiDA cells were evaluated by use of an 
amphetamine-induced rotation test. Our results indicated 
that the control (IMR90) cells injected PD animals showed 
increasingly higher rotary behavior over the course of ex-
periment. In contrast, the PD animals transplanted with the 
reprogrammed hiDA cells showed significant reduction in 
rotational scores at both four and eight weeks after trans-
plantation (Figure 5A, P<0.05).  
Eight weeks after transplantation, the rats were sacrificed 
and examined for the survival of grafted hiDA cells with a 
human cell-specific antibody. Tyrosine hydroxylase im-
munohistochemistry analysis showed that the grafted cells 
were located in coronal sections of rat brain injection sites 
(Figure 5B). Immunofluorescence staining further con-
firmed that the grafted cells (those staining positive for HN, 
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Figure 3  Neuron-specific gene expression in hiDA cells. A, Quantitative PCR analysis of neural and DA specific gene expression in 5F+p53-DN trans-
duced IMR90 cells at 20 d after infection. B, Quantitative PCR analysis of the total and endogenous expression of five transcription factors in 5F+p53-DN 
transduced IMR90 cells at 20 d after infection. The error bars represent standard error of the mean (SEM).  
 
Figure 4  Functional characterization of hiDA cells. A, Dopamine uptake of hiDA neurons. The specific [3H]dopamine uptake was detected 5F+p53-DN 
transduced IMR90 cells at day 24 after transduction. Error bars indicate standard error of the mean (SEM, n=4). B, Dopamine release of hiDA neurons. C, 
SYP (synaptophysin) co-expression with Tuj1 in 5F+p53-DN transduced IMR90 cells at 20 days after gene transduction. Scale bar, 200 m. D, Quantitative 
PCR analysis of SYP and SYN gene expression in 5F+p53-DN transduced IMR90 cells at 20 d after gene transduction. 
human nuclear protein) stained positive for TH and local-
ized around the injection area (Figure 5C). Furthermore, no 
Ki67 positive cells were found in any of the brain sections 
despite thorough examination (data not shown). This was 
true for all animals examined regardless of the cells being 
transplanted were IMR90 or hiDA cells. Our results thus 
indicated that transplantation of 5F+p53-DN transduced 
hiDA cells could relieve the PD symptoms in rat PD model, 
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Figure 5  Symptomatic relief in a Parkinsonian rat model mediated by hiDA cell derived from 5F+p53-DN transduced IMR90 cells. Amphetamine-induced 
rotational behaviors (duration: 180 min) in 6-OHDA lesioned rats before cell engraftment, and at 4 and 8 weeks after the transplantation of reprogrammed 
cells (about 6×105, DIV12) or IMR90 cells (control) into the middle of striatum on the lesioned side. Transplantation of reprogrammed cells significantly 
prevented a steady increase in amphetamine-induced rotation scores in 6-OHDA lesioned rats at both 4 and 8 weeks after transplantation (*, P<0.05). Error 
bars indicate standard error of the mean (SEM, n=10 for reprogrammed cells group and n=4 for control group). A, Coronal section of rat brain showing the 
6-OHDA lesion area and the site of hiDA injection. Immunohistochemical analyses with tyrosine hydroxylase antibody and diaminobenzidine (TH/DAB) 
staining notices the strong staining of tyrosine hydroxylase in both the lesioned striatum and injection site. B, Expression of tyrosine hydroxylase in repro-
grammed cells at the injection site. TH, tyrosine hydroxylase; HN, human nucleus protein, a marker for injected, reprogrammed human hiDA cells. Nuclei 
were stained with DAPI. Scale bar, 50 m. 
but did not lead to any visible cellular proliferation, which 
would suggest increased carcinogenic risk.   
3  Discussion 
Direct reprogramming of somatic cells into dopaminergic 
neurons provides an alternative source of DA neurons that 
significantly reduce the carcinogenic risks inherent in the 
iPSC-differentiation approach. However, one of the major 
obstacles in using the hiDA cells is the low reprogramming 
efficiency encountered in the published methods. Most pre-
vious studies have very low frequency of direct reprogram-
ming efficiency due to cell death. A significant boost in 
reprogramming efficiency is needed before hiDA is to be 
used in treating patients.  
In the present study, we show that the efficiency of suc-
cessful reprogramming could be significantly elevated by 
inhibition of p53 in direct reprogramming process. Im-
portantly, we found that increased efficiency was mainly 
achieved through enhanced cellular survival but not cellular 
proliferation, thus reducing the likelihood of oncogenesis 
caused by p53 inhibition. Of course, the safety of such cells 
should be further evaluated in longer term studies to ensure 
874 Liu XJ, et al.   Sci China Life Sci   September (2014) Vol.57 No.9 
their safety before any human studies are initiated. 
Our finding that inhibition of p53 enhances the efficiency 
of transcription factor-mediated direct reprogramming of 
fibroblast into dopaminergic neurons is consistent with ear-
lier findings on the role of p53 as a “guardian of repro-
gramming” [15,24]. In those studies, p53 is identified as a 
key barrier involved in preventing the generation of mouse 
and human induced pluripotent cells (iPSCs) [15,17,18,25]. 
Similar to our study, the suppression of p53 increased the 
efficiency of human and mouse iPS cell generation. How-
ever, despite the similarities in enhanced reprogramming 
efficiencies, it is not clear if p53 plays exactly the same 
roles in the direct reprogramming vs. the iPSC induction 
processes: while our evidence points to a main role for p53 
inhibition in direct reprogramming to that of boosting sur-
vival of cells placed in neuron-specific medium, it is not 
clear what exactly is the role of p53 inhibition in the iPSC 
inducing process.  
Our present study demonstrates that suppression of p53 
protein augments the reprogramming efficiency in direct 
reprogramming of fibroblast into functional dopaminergic 
neurons. Furthermore, we found that improved efficiency is 
achieved through increasing cellular survival rate rather 
than cell proliferation. Increased dopaminergic neuron gen-
eration in this way will not only improve the feasibility of 
translating our discovery into the clinic but also facilitate 
understanding of the underlying biological mechanisms 
associated with trans-differentiation, and thus improving 
efficiency of direct reprogramming of other types of poten-
tially useful cells. 
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Supporting Information 
Figure S1  A, Linearity of bioluminescence vs. IMR90 cell numbers. Luc gene transduced IMR90 cells were plated in 12 well plates in different numbers. 
Then, cells were imaged by use of the IVIS200 imaging system. Top panel, luc activities plotted against cell number (R2=0.970). Error bars represent stand-
ard error of the mean (SEM, n=3). Lower panel, a representative luciferase image of the plated IMR90 cells. B, P21 is a target of p53 in the reprogramming 
process. Western blot analysis of p53 and p21 protein expression in 5F (upper panel) or 5F-p53-DN (lower panel) transduced IMR90 cells at indicated times. 
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